Future studies could explore the potential of such a personalized approach using SNPs in DM1 too, since complete elimination of expanded DMPK transcripts would likely improve DM1 pathology, assuming that DMPK haploinsufficiency is not too harmful in humans [48]. This evidence concerns the gene DMPK and myotonic dystrophy type 1.